Form 8-K - Current report:
SEC Accession No. 0001493152-26-000834
Filing Date
2026-01-07
Accepted
2026-01-07 17:00:52
Documents
12
Period of Report
2025-12-31
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 40900
  Complete submission text file 0001493152-26-000834.txt   207259

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ppcb-20251231.xsd EX-101.SCH 3011
3 XBRL LABEL FILE ppcb-20251231_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ppcb-20251231_pre.xml EX-101.PRE 22356
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3190
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-42806 | Film No.: 26516421
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)